Beyond the CAR-mediated cytotoxicity, γδ T cells can recognize tumor cells through their intrinsic receptors, including Vδ1 TCR, CD16, NKG2D, and NKp30, and activate various natural tumor-killing pathways. The gene discussed is KLRK1; the disease is neoplasm.